|Publication number||USRE38730 E1|
|Application number||US 09/838,300|
|Publication date||Apr 26, 2005|
|Filing date||Apr 20, 2001|
|Priority date||May 5, 1995|
|Publication number||09838300, 838300, US RE38730 E1, US RE38730E1, US-E1-RE38730, USRE38730 E1, USRE38730E1|
|Inventors||Steven M. Gann, John R. Wells|
|Original Assignee||Harvest Technologies Corporation|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (38), Referenced by (39), Classifications (5), Legal Events (2)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This application is a division of U.S. application Ser. No. 08/435,662, which was filed on May 5, 1995, now U.S. Pat. No. 5,707,331.
This invention relates to the art of automatic centrifugation. In particular, the invention relates to apparatus and procedures using automatic, multiple decanting with centrifugation. In a preferred embodiment, an automated procedure separates blood components and proteins including the separation of fibrinogen from blood.
The separation of components through centrifugation is well known. For example, in the medical field it is common to subject a sample of blood to centrifugation to produce a precipitate of cellular material and a supernatant of plasma. The plasma is then decanted to complete the separation of these components.
U.S. Pat. Nos. 5,178,602 (Wells) and 5,047,004 (Wells) show an automated centrifuge, which includes structure for holding a centrifuge tube, after centrifugation, in a position that allows the supernatant to drain from the tube and into another container by gravity. The holding structure shown in these patents comprises a locking mechanism mounted for axial movement with respect to the axis of rotation of the centrifuge. An electromagnet that is easily controlled causes the axial movement.
It is also known to decant a supernatant by the process of centrifugal draining. According to that process, a centrifuge rotates a centrifuge tube while the tube is held in a position such that the supernatant is drained from the tube by centrifugal forces.
Fibrin sealants for treating wounds are known and are typically produced by combining a fibrinogen/Factor XIII component with bovine thrombin. When these are mixed, a fibrin tissue adhesive results, which is applied to the wound. Descriptions of compositions for use as tissue sealants are given in U.S. Pat. Nos. 5,292,362 and 5,209,776 (Bass et al.). The fibrinogen is obtained from plasma, either pooled or autologous, and cryoprecipitation is one known technique for separating fibrinogen from plasma. One cryoprecipitation technique is described in U.S. Pat. Nos. 5,318,524 and includes the centrifugation of thawing plasma to produce a precipitate containing fibrinogen/Factor XIII. Other techniques for producing fibrinogen/Factor XIII include inducing precipitation of the component by addition of such agents as Ammonium Sulfate or polyethylene glycol (PEG) to blood plasma.
Several known chemical procedures include repeated steps of physical separation between two or more components. Separation based on density differences between the components is often by centrifugation, and the resulting supernatant is decanted to complete the separation. Each step provides an opportunity for error, which would be reduced by automation of the process.
In accordance with the invention, chemical procedures requiring several centrifugation steps are automated, to reduce the time required by a clinician and eliminate the potential for errors. Apparatus in accordance with the invention includes a multiple-chamber container and a centrifuge designed to receive the container and subject its contents to predetermined centrifugation steps as well as gravity and centrifugal decanting of the supernatant.
A preferred container in accordance with the invention includes first and second chambers separated by an intermediate wall. The first chamber is designed to receive a first liquid, such as human blood. The second chamber is located adjacent the first chamber, and the wall between the chambers is such that a supernatant in the first chamber will flow over the top of the wall and be drained into the second chamber by gravity when the container is held in the proper orientation. The supernatant in the second chamber may then be subjected to a mixing action and then may be subjected to a second centrifugation. The container can also be held in a second position whereby a second supernatant is caused to flow back over the wall into the first chamber by centrifugal forces resulting from a second centrifugation.
A centrifuge in accordance with the invention includes a rotatable support with a swinging frame for receiving the multiple-chamber container and means for locking the container in either of at least two positions for draining supernatant fluids from the chambers. Preferably, the locking means is an electro-magnetically operated disk mounted for movement axially with respect to the axis of rotation of the rotatable support. The centrifuge is preferably operated under the control of an electronic circuit, which may include a programmed array logic (PAL) or other circuitry, that causes the rotor to operate in accordance with a predetermined program and controls the locking means such that it locks the container in predetermined orientations in conjunction with operation of the rotor.
While many different programs for operation of the centrifuge can be developed, depending on the desired results, a preferred operation is for the production of autologous fibrinogen. Prior techniques for production of fibrinogen require several distinct steps, each of which requires a skilled technician but does not eliminate an opportunity for error. These steps include separation of plasma from cellular components, treatment of the plasma with a precipitating agent, and separation of a fibrinogen precipitate “pellet” from the plasma. The separation of plasma from blood and the separation of the fibrinogen pellet from plasma typically require centrifugation first of the blood and then of the plasma, with addition of at least one precipitating agent between the steps. Thus, the production of fibrinogen in the prior art has been complex and error-prone.
In accordance with this embodiment of the invention, a volume of the patient's anticoagulated blood is placed in the first chamber of the disposable container, and a precipitation agent is placed in the second of the chambers. The container is then placed in the swinging frame of the centrifuge, and the control circuit is activated to initiate the operation of the centrifuge. The centrifuge first rotates the container for a time period that has been determined to be adequate for separating the cellular components from the supernatant plasma. During this time, the swinging frame will have rotated outwardly substantially due to centrifugal forces on the container. While the frame is in the outwardly rotated position, the locking means is activated to lock it there. The rotation of the support is then terminated. As the rotational velocity of the support decreases, the supernatant fluid, being no longer subject to the centrifugal forces, flows out of the first chamber and into the second chamber by gravity. The cellular component is more viscous and, thus, flows toward the second chamber at a rate less than that of the plasma. Preferably, however, a divider in the form of a disk is placed in the first chamber to restrict the flow of the cellular components and plasma below the disk. The disk is at a depth that provides a predetermined volume of plasma, which is normally near the expected boundary between the supernatant and cellular components. After a period of time that has been determined to allow an adequate amount of the plasma to flow into the second chamber, the locking means is deactivated to release the container, whereby it assumes an upright position with the cellular component remaining in the first chamber and the plasma now in the second chamber. The rotatable support is then alternately activated and deactivated for short intervals to mix the plasma with the precipitating agent in the second chamber. Interaction between the precipitating agent and the plasma initiates precipitation of fibrinogen and Factor XIII from the plasma. The support is then again rotated to accelerate the precipitation of the fibrinogen/Factor XIII and to create a pellet in the bottom of the second chamber. As a final step, the locking means is again activated to lock the container in a position such that the supernatant resulting from precipitation of the fibrinogen is decanted by centrifugal draining into the first chamber. In this step, the container is held substantially upright, and the support is rotated to apply centrifugal forces to the supernatant, whereby it flows over the wall between the chambers and into the first chamber. The locking means is then inactivated, the container removed from the centrifuge, and the fibrinogen/Factor XIII removed from the second chamber for further processing. In a preferred embodiment, the fibrinogen/Factor XIII is reconstituted, and then combined with thrombin, and applied to a patient to treat a wound.
With reference to
A preferred form of the container is shown in detail in FIG. 2. As shown, the container comprises three primary parts. A base part is preferably molded and includes the chambers 6 and 8 and a bridge 7, which connects the two chambers. A lid 11, also preferably molded, fits over the tops of the chambers to close them. The lid includes cup shaped extensions 12 and 14, each of which is centrally aligned with a respective one of the chambers 6 and 8. Extension 12 has a access port in the form of centrally located opening 13, while extension 14 has a centrally located opening 15. The openings receive syringe needles to permit fluids to be injected into the chambers or withdrawn therefrom. Membranes 16 and 17 cover the openings 13 and 15 to maintain sterility. The membranes are preferably heat sealed into the extensions 12 and 14 during construction by providing a cavity for receiving the membranes. After a membrane is inserted, the upper edges of the cavity are folded over and welded, e.g., ultrasonically, to retain the membrane.
The lid also includes a bridge 7′ that cooperates with bridge 7 in the base to form a fluid channel 18, connecting chambers 6 and 8. As shown, the bridge 7 extends above the tops of the chambers 6 and 8 to prevent communication between the chambers by “splashing.” Intentional fluid communication between the two chambers will be described in detail below.
A separation disk 20 is preferably placed in chamber 6 near, but always above, the expected vertical position of the boundary between supernatant plasma and cellular components after a first centrifugation of a blood sample. The hematocrit is known to vary among individuals, and the exact amount of plasma that will result from a blood sample cannot be accurately predicted without prior testing of the sample. Thus, disk 20 is located such that the plasma above the disk after centrifugation of a predetermined volume of blood is a predetermined volume of plasma. The upper surface of the disk 20 is tapered toward an edge, and the edge includes at least one groove 22 that allows fluid communication between the parts of the chamber 6 that are above and below the disk 20.
In a preferred embodiment, a cylindrical support 24 is attached to the lower surface of the disk to set the location of the disk during assembly.
A hollow tube 26 is provided to facilitate introduction of the blood sample to the portion of the chamber 6 that is below the disk 20. The tube 26 extends from just below the opening 13 through disk 20. Thus, a syringe needle inserted through opening 13 pierces membrane 16 and communicates with tube 26 to allow injection of the blood sample into the bottom of the chamber 6. The groove 22 permits downward movement of the plasma and cellular components during centrifugation but retards movement of the cellular components during decanting. Also, an air vent 27 is provided for chamber 8 to facilitate introduction and withdrawal of fluids.
In use, a container 4 is placed in a holder on the rotor of the centrifuge as indicated in FIG. 1. To balance the rotor, two such containers are preferably placed in the centrifuge in diametrically opposed positions. Of course, only one container may be used and a weight or “dummy” container used to balance the rotor.
A locking plate 36 is mounted coaxially with the shaft 28 for engaging the frame 32 to lock the container in desired orientations. The plate and the mechanism for controlling the positions of the plate may be the substantially the same as that shown in my previous U.S. Pat. No. 5,178,602. For example, an electromagnet 38 may be provided to control the position of the locking plate by action on a permanent magnet 40, which is attached to the locking plate.
Preferably, the electromagnet 38 and magnet 40 are positioned such that the locking plate can be placed in either of two positions. In a first position, shown in phantom lines, the plate does not engage the frame 32, and the frame 32 is free to rotate about pivot 34. In a second position, shown in solid lines at 36′, the locking plate engages one of two parts of the frame 32 to hold it in one of two selected orientations. In the position shown in
The operation of the centrifuge in a preferred embodiment of the invention will be described with regard to
In the first step of automated operation, the container is allowed to swing freely as the blood is subjected to centrifugation. As illustrated in
Plasma 46 is separated from the fibrinogen pellet 48 by stopping rotation of the centrifuge rotor to allow the container to pivot to the upright position shown in
The automated process for production of fibrinogen is at this point complete, and the fibrinogen pellet is preferably extracted from the container 8 by a syringe for further processing. For example, the fibrinogen may be reconstituted and combined with thrombin to produce a sealant or an adhesive.
The apparatus of the invention may be used for other automated processes. For example, another technique for the separation of fibrinogen from blood in accordance with the structure of the invention uses cryoprecipitation. According to this technique, plasma is frozen to a temperature of about minus 20° C., thawed, and then centrifuged to separate the fibrinogen from plasma. The multiple-decanting apparatus of this invention may be used to automate cryoprecipitation by inclusion of a temperature control device 50 in thermal contact with the centrifuge. The temperature control device may comprise any of several known structures, including liquid nitrogen or liquid oxygen based devices and refrigeration devices.
To effect automated cryoprecipitation, a sample of blood is placed in the first chamber 8, and the container is then placed in the centrifuge and subjected to a first centrifugation. The plasma is then drained into the second chamber 8, for example by gravity draining. The temperature control device is then activated first to freeze the plasma and then to allow the plasma to thaw. The thawed plasma is subjected to a second centrifugation, which separates fibrinogen from the remainder of the plasma. The supernatant plasma is then separated from the fibrinogen by draining it back into the first chamber, for example by centrifugal draining, whereby only fibrinogen remains in the second chamber. The container is then removed from the centrifuge, and the fibrinogen removed from it for use as described above. Of course, the freeze-thaw-centrifuge process may be carried out any number of times before the supernatant is drained back into the first chamber.
Modifications within the scope of the appended claims will be apparent to those of skill in the art.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US1722396 *||Feb 13, 1928||Jul 30, 1929||Winfield S Reiber||Milk bottle|
|US3164186 *||Jul 13, 1962||Jan 5, 1965||Imogene D Abrams||Plastic container|
|US3190546 *||Mar 27, 1959||Jun 22, 1965||Raccuglia Giovanni||Method and apparatus for separating liquid mixtures|
|US3221741 *||Jun 18, 1962||Dec 7, 1965||Veen Harry H Le||Container for collecting and storing blood having anticoagulant means therein|
|US3228444 *||Nov 18, 1964||Jan 11, 1966||Eberhard E H Weber||Specimen container|
|US3235069 *||Sep 21, 1962||Feb 15, 1966||Eschmann Bros & Walsh Ltd||Sterile container|
|US3420437 *||Jan 5, 1968||Jan 7, 1969||Sorvall Inc Ivan||Cell washing centrifuge|
|US3586484 *||May 23, 1969||Jun 22, 1971||Atomic Energy Commission||Multistation analytical photometer and method of use|
|US3642163 *||Mar 20, 1970||Feb 15, 1972||Mcfarland Lorrell C||Multitubular pressure tank|
|US3712535 *||Sep 2, 1971||Jan 23, 1973||Becton Dickinson Co||Centrifuge rotor and sample holder with agitating means|
|US3722789 *||Jan 31, 1972||Mar 27, 1973||American Hospital Supply Corp||Centrifuge and self positioning tube holder therefor|
|US3727788 *||Dec 9, 1970||Apr 17, 1973||Medical Dev Corp||Fluid container structure having mutually cooperable port connections|
|US3774455 *||Dec 22, 1971||Nov 27, 1973||H Feldman||Urine testing apparatus|
|US3851817 *||May 29, 1973||Dec 3, 1974||Buck E||Method and means for centrifuging chilled blood samples|
|US3859671 *||Apr 13, 1973||Jan 14, 1975||Marianna Tomasello||Urine container for urinalysis|
|US3877634 *||May 25, 1973||Apr 15, 1975||Du Pont||Cell washing centrifuge apparatus and system|
|US3951334 *||Jul 7, 1975||Apr 20, 1976||E. I. Du Pont De Nemours And Company||Method and apparatus for automatically positioning centrifuge tubes|
|US3953172 *||May 10, 1974||Apr 27, 1976||Union Carbide Corporation||Method and apparatus for assaying liquid materials|
|US4026433 *||Jan 15, 1976||May 31, 1977||Egidia Crippa||Container provided with an outer testpiece for the analysis of urine and other acid liquids|
|US4066407 *||Dec 16, 1976||Jan 3, 1978||Vincent Lupica||Body fluid testing system and process|
|US4150089 *||Sep 6, 1977||Apr 17, 1979||Linet Michael S||Multi-chamber test tube|
|US4285463 *||Nov 1, 1979||Aug 25, 1981||American Hospital Supply Corporation||Decanting centrifuge|
|US4294372 *||Oct 29, 1979||Oct 13, 1981||Nippon Clean Engine Laboratory Co.||Small-sized container capable of mixing more than two components at a predetermined mixing ratio|
|US4431423 *||Mar 10, 1982||Feb 14, 1984||E. I. Du Pont De Nemours & Co.||Cell washing apparatus having radially inwardly directed retaining arms|
|US4714457 *||Sep 15, 1986||Dec 22, 1987||Robert Alterbaum||Method and apparatus for use in preparation of fibrinogen from a patient's blood|
|US4932546 *||Mar 16, 1989||Jun 12, 1990||Buttes Gas & Oil Co.||Pressure vessel|
|US5045047 *||Jul 17, 1989||Sep 3, 1991||Zymark Corporation||Automated centrifuge|
|US5047004 *||Feb 7, 1990||Sep 10, 1991||Wells John R||Automatic decanting centrifuge|
|US5178602 *||Sep 9, 1991||Jan 12, 1993||Wells John R||Automatic decanting centrifuge|
|US5199937 *||Jun 2, 1992||Apr 6, 1993||Kurashiki Boseki Kabushiki Kaisha||Centrifugal separator|
|US5209776 *||Jul 27, 1990||May 11, 1993||The Trustees Of Columbia University In The City Of New York||Tissue bonding and sealing composition and method of using the same|
|US5292362 *||Jul 9, 1991||Mar 8, 1994||The Trustees Of Columbia University In The City Of New York||Tissue bonding and sealing composition and method of using the same|
|US5318524 *||Mar 2, 1992||Jun 7, 1994||Cryolife, Inc.||Fibrin sealant delivery kit|
|US5447245 *||Jul 20, 1993||Sep 5, 1995||Merhar; Richard D.||Graduated proportioning and mixing container|
|US5503284 *||Dec 23, 1994||Apr 2, 1996||Li; Hofman Y.||Single continuous wall, multi-chamber container|
|CA461698A *||Dec 13, 1949||Julius Langstadt||Compartmented receptacle|
|DE4323844A1 *||Jul 16, 1993||Jan 19, 1995||Hettich Andreas Fa||Washing centrifuge|
|FR936560A *||Title not available|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7780860||May 19, 2008||Aug 24, 2010||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US7806276||Apr 11, 2008||Oct 5, 2010||Hanuman, Llc||Buoy suspension fractionation system|
|US7832566||May 25, 2006||Nov 16, 2010||Biomet Biologics, Llc||Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles|
|US7837884||Dec 29, 2008||Nov 23, 2010||Hanuman, Llc||Methods and apparatus for isolating platelets from blood|
|US7845499||May 25, 2006||Dec 7, 2010||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US7914689||May 19, 2008||Mar 29, 2011||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US7992725||Apr 11, 2008||Aug 9, 2011||Biomet Biologics, Llc||Buoy suspension fractionation system|
|US8048321||Aug 11, 2010||Nov 1, 2011||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US8062534||Dec 6, 2010||Nov 22, 2011||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US8119013||Oct 4, 2010||Feb 21, 2012||Hanuman, Llc||Method of separating a selected component from a multiple component material|
|US8152708 *||Apr 19, 2010||Apr 10, 2012||Harvest Technologies Corporation||Decanting centrifuge with sliding engagement between decant ring and processing unit|
|US8163184||Mar 25, 2011||Apr 24, 2012||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US8187477||Nov 22, 2010||May 29, 2012||Hanuman, Llc||Methods and apparatus for isolating platelets from blood|
|US8221301 *||Apr 30, 2007||Jul 17, 2012||Hyun-Jin Yang||Centrifuge having an angle adjuster and centrifuging method|
|US8309343||Dec 1, 2008||Nov 13, 2012||Baxter International Inc.||Apparatus and method for processing biological material|
|US8313954||Apr 3, 2009||Nov 20, 2012||Biomet Biologics, Llc||All-in-one means of separating blood components|
|US8328024||Aug 4, 2011||Dec 11, 2012||Hanuman, Llc||Buoy suspension fractionation system|
|US8337711||Feb 27, 2009||Dec 25, 2012||Biomet Biologics, Llc||System and process for separating a material|
|US8567609||Apr 19, 2011||Oct 29, 2013||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US8591391||Apr 12, 2010||Nov 26, 2013||Biomet Biologics, Llc||Method and apparatus for separating a material|
|US8596470||Feb 20, 2012||Dec 3, 2013||Hanuman, Llc||Buoy fractionation system|
|US8603346||Sep 22, 2011||Dec 10, 2013||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US8783470||May 25, 2012||Jul 22, 2014||Biomet Biologics, Llc||Method and apparatus for producing autologous thrombin|
|US8801586 *||Dec 20, 2012||Aug 12, 2014||Biomet Biologics, Llc||System and process for separating a material|
|US8808551||Nov 15, 2010||Aug 19, 2014||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US8950586||Jul 1, 2013||Feb 10, 2015||Hanuman Llc||Methods and apparatus for isolating platelets from blood|
|US8992862||Nov 15, 2012||Mar 31, 2015||Biomet Biologics, Llc||All-in-one means of separating blood components|
|US9011800||Jul 16, 2009||Apr 21, 2015||Biomet Biologics, Llc||Method and apparatus for separating biological materials|
|US9097631||Sep 14, 2012||Aug 4, 2015||Baxter International Inc.||Apparatus and method for processing biological material|
|US9114334||Dec 9, 2013||Aug 25, 2015||Biomet Biologics, Llc||Apparatus and method for separating and concentrating fluids containing multiple components|
|US9138664||Dec 2, 2013||Sep 22, 2015||Biomet Biologics, Llc||Buoy fractionation system|
|US9176038||Sep 12, 2012||Nov 3, 2015||Baxalta Incorporated||Apparatus and method for processing biological material|
|US9182328||Sep 12, 2012||Nov 10, 2015||Baxalta Incorporated||Apparatus and method for processing biological material|
|US20020192805 *||Jun 13, 2001||Dec 19, 2002||Harris Ian Ross||Devices and methods for cell harvesting|
|US20060094865 *||Oct 29, 2004||May 4, 2006||Kapur Terri A||Intraoperative method for isolating and concentrating autologous growth factors and for forming residual autologous growth factor compositions|
|US20070276191 *||May 26, 2006||Nov 29, 2007||Sean Selover||Illuminated surgical access system including a surgical access device and integrated light emitter|
|US20090312169 *||Apr 30, 2007||Dec 17, 2009||Hyun-Jin Yang||Centrifuge and centrifuging method|
|US20100112696 *||Mar 20, 2009||May 6, 2010||Baxter International Inc.||Apparatus And Methods For Processing Tissue To Release Cells|
|US20100136679 *||Dec 1, 2008||Jun 3, 2010||Baxter International Inc.||Apparatus and Method for Processing Biological Material|
|U.S. Classification||494/37, 210/782|
|Oct 20, 2006||FPAY||Fee payment|
Year of fee payment: 8
|Oct 20, 2010||FPAY||Fee payment|
Year of fee payment: 12